{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:22:36Z","timestamp":1787318556550,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"IDCCM, University of Toronto"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>We sought to evaluate the effectiveness of any antiseizure medication on the incidence of early post-traumatic seizures among adult patients with traumatic brain injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>MEDLINE, Embase, PubMed, Cochrane Central Register of Controlled Trials, and LILACS were searched from inception to October 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY SELECTION:<\/jats:title>\n                    <jats:p>We included randomized trials of adult patients with traumatic brain injury evaluating any antiseizure medication compared with either placebo or another agent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA EXTRACTION:<\/jats:title>\n                    <jats:p>Two reviewers independently extracted individual study data and evaluated studies for risk of bias using the Cochrane Risk of Bias tool. Our main outcome of interest was the occurrence of early seizures (i.e., within 7 d); secondary outcomes included late-seizures and all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SYNTHESIS:<\/jats:title>\n                    <jats:p>Bayesian network meta-analyses were used to derive risk ratios (RRs) alongside 95% credible intervals (CrIs). We used Grading of Recommendations Assessment, Development, and Evaluation methodology to rate the certainty in our findings. Overall, ten individual randomized controlled trials (1851 participants) were included. Compared with placebo, phenytoin (RR, 0.28; 95% CrI, 0.13\u20130.57; moderate certainty) and levetiracetam (RR, 0.20; 95% CrI, 0.07\u20130.60; moderate certainty) were associated with a reduction in the risk of early seizures. Carbamazepine may be associated with a reduced risk of early seizures, but the evidence is very uncertain (RR, 0.41; 95% CrI, 0.12\u20131.27; very low certainty). Valproic acid may result in little to no difference in the risk of early seizures, but the evidence is very uncertain (RR, 0.97; 95% CrI, 0.16\u20139.00; very low certainty). The evidence is very uncertain about the impact of any antiseizure medication on the risk of late seizures or all-cause mortality at longest reported follow-up time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Phenytoin or levetiracetam reduce the risk of early seizures among adult patients with traumatic brain injury. Further research is needed to evaluate required duration of therapy and long-term safety profiles.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cce.0000000000001160","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T10:07:24Z","timestamp":1727345244000},"page":"e1160","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Antiseizure Medications in Adult Patients With Traumatic Brain Injury: A Systematic Review and Bayesian Network Meta-Analysis"],"prefix":"10.1097","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0971-386X","authenticated-orcid":false,"given":"Federico","family":"Angriman","sequence":"first","affiliation":[{"name":"Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada."},{"name":"Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada."},{"name":"Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaurya","family":"Taran","sequence":"additional","affiliation":[{"name":"Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada."},{"name":"Toronto Western Hospital, University Health Network, Toronto, ON, Canada."},{"name":"Institute for Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Angeloni","sequence":"additional","affiliation":[{"name":"Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada."},{"name":"Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada."},{"name":"Institute for Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Devion","sequence":"additional","affiliation":[{"name":"Library Services, Sunnybrook Health Sciences Centre, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Woo","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neill K. J.","family":"Adhikari","sequence":"additional","affiliation":[{"name":"Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada."},{"name":"Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada."},{"name":"Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada."},{"name":"Institute for Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,25]]},"reference":[{"key":"R1-20241001","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1474-4422(18)30415-0","article-title":"Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016.","volume":"18","author":"James","year":"2019","journal-title":"Lancet Neurol"},{"key":"R2-20241001","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jamaneurol.2021.5420","article-title":"Risk factors and prognosis of early posttraumatic seizures in moderate to severe traumatic brain injury.","volume":"79","author":"Laing","year":"2022","journal-title":"JAMA Neurol"},{"key":"R3-20241001","doi-asserted-by":"crossref","first-page":"e2140191","DOI":"10.1001\/jamanetworkopen.2021.40191","article-title":"Association of posttraumatic epilepsy with 1-year outcomes after traumatic brain injury.","volume":"4","author":"Burke","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R4-20241001","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4103\/ajns.AJNS_125_17","article-title":"Comparison of phenytoin versus levetiracetam in early seizure prophylaxis after traumatic brain injury, at a tertiary care hospital in Karachi, Pakistan.","volume":"13","author":"Younus","year":"2018","journal-title":"Asian J Neurosurg"},{"key":"R5-20241001","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12028-009-9304-y","article-title":"Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis.","volume":"12","author":"Szaflarski","year":"2010","journal-title":"Neurocrit Care"},{"key":"R6-20241001","first-page":"29","article-title":"Magnesium sulfate for neuroprotection after traumatic brain injury: A randomised controlled trial.","volume":"6","author":"Temkin","year":"2007","journal-title":"Lancet Resp Med"},{"key":"R7-20241001","first-page":"311","article-title":"Cooperative prospective study on posttraumatic epilepsy: Risk factors and the effect of prophylactic anticonvulsant.","volume":"46","author":"Manaka","year":"1992","journal-title":"Jpn J Psychiatry Neurol"},{"key":"R8-20241001","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3171\/jns.1983.58.2.0231","article-title":"Failure of prophylactically administered phenytoin to prevent early posttraumatic seizures.","volume":"58","author":"Young","year":"1983","journal-title":"J Neurosurg"},{"key":"R9-20241001","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/jnnp.46.10.899","article-title":"Low risk of late post-traumatic seizures following severe head injury: Implications for clinical trials of prophylaxis.","volume":"46","author":"McQueen","year":"1983","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R10-20241001","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJM199008233230801","article-title":"A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures.","volume":"323","author":"Temkin","year":"1990","journal-title":"N Engl J Med"},{"key":"R11-20241001","first-page":"455","article-title":"Comparison of efficacy of phenytoin and levetiracetam for prevention of early post traumatic seizures.","volume":"28","author":"Khan","year":"2016","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"R12-20241001","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1227\/NEU.0000000000001445","article-title":"Should levetiracetam or phenytoin be used for posttraumatic seizure prophylaxis? A systematic review of the literature and meta-analysis.","volume":"79","author":"Khan","year":"2016","journal-title":"Neurosurgery"},{"key":"R13-20241001","doi-asserted-by":"crossref","first-page":"1001363","DOI":"10.3389\/fphar.2022.1001363","article-title":"Effectiveness of antiseizure medications therapy in preventing seizures in brain injury patients: A network meta-analysis.","volume":"13","author":"Huo","year":"2022","journal-title":"Front Pharmacol"},{"key":"R14-20241001","doi-asserted-by":"crossref","first-page":"101394","DOI":"10.1016\/j.inat.2021.101394","article-title":"Levetiracetam vs phenytoin prophylaxis in severe traumatic brain injury: Systematic review and meta-analysis.","volume":"27","author":"McGinn","year":"2022","journal-title":"Interdiscip Neurosurg"},{"key":"R15-20241001","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s12028-023-01907-x","article-title":"Guidelines for seizure prophylaxis in adults hospitalized with moderate\u2013severe traumatic brain injury: A clinical practice guideline for health care professionals from the Neurocritical Care Society.","volume":"40","author":"Frontera","year":"2024","journal-title":"Neurocrit Care"},{"key":"R16-20241001","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement.","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"R17-20241001","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations.","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"R18-20241001","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","article-title":"Guidelines for the management of severe traumatic brain injury, fourth edition.","volume":"80","author":"Carney","year":"2017","journal-title":"Neurosurgery"},{"key":"R19-20241001","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R20-20241001","first-page":"g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis.","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ (Online)"},{"key":"R21-20241001","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1164\/rccm.202006-2381CP","article-title":"Using Bayesian methods to augment the interpretation of critical care trials. An overview of theory and example reanalysis of the alveolar recruitment for acute respiratory distress syndrome trial.","volume":"203","author":"Zampieri","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"R22-20241001","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/0272989X12458724","article-title":"Evidence synthesis for decision making 2: A generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials.","volume":"33","author":"Dias","year":"2013","journal-title":"Med Decis Making"},{"key":"R23-20241001","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/sim.6381","article-title":"Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis.","volume":"34","author":"Turner","year":"2015","journal-title":"Stat Med"},{"key":"R24-20241001","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(74)91639-0","article-title":"Assessment of coma and impaired consciousness. A practical scale.","volume":"2","author":"Teasdale","year":"1974","journal-title":"Lancet"},{"key":"R25-20241001","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13049-021-00873-7","article-title":"The definition of major trauma using different revisions of the abbreviated injury scale.","volume":"29","author":"Van Ditshuizen","year":"2021","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"R26-20241001","doi-asserted-by":"crossref","first-page":"E901","DOI":"10.1503\/cmaj.200077","article-title":"Development of the instrument to assess the credibility of effect modification analyses (ICEMAN) in randomized controlled trials and meta-analyses.","volume":"192","author":"Schandelmaier","year":"2020","journal-title":"CMAJ"},{"key":"R27-20241001","doi-asserted-by":"crossref","first-page":"m3900","DOI":"10.1136\/bmj.m3900","article-title":"GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework.","volume":"371","author":"Brignardello-Petersen","year":"2020","journal-title":"BMJ"},{"key":"R28-20241001","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jclinepi.2021.07.011","article-title":"GRADE guidelines 33: Addressing imprecision in a network meta-analysis.","volume":"139","author":"Brignardello-Petersen","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"R29-20241001","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jclinepi.2022.07.014","article-title":"GRADE guidance 34: Update on rating imprecision using a minimally contextualized approach.","volume":"150","author":"Zeng","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"R30-20241001","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: Informative statements to communicate the findings of systematic reviews of interventions.","volume":"119","author":"Santesso","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"R31-20241001","first-page":"66","article-title":"[Seizure prevention using carbamazepine following severe brain injuries].","volume":"26","author":"Glotzner","year":"1983","journal-title":"Neurochirurgia (Stuttg)"},{"key":"R32-20241001","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3171\/jns.1983.58.2.0236","article-title":"Failure of prophylactically administered phenytoin to prevent late posttraumatic seizures.","volume":"58","author":"Young","year":"1983","journal-title":"J Neurosurg"},{"key":"R33-20241001","first-page":"841","article-title":"Pr\u00e9vention de l\u2019\u00e9pilepsie post-traumatique tardive par ph\u00e9nyto\u00efne dans les traumatismes cr\u00e2niens graves: Suivi durant 2 ans.","volume":"20","author":"Pechadre","year":"1991","journal-title":"Presse Med"},{"key":"R34-20241001","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3171\/jns.1999.91.4.0593","article-title":"Valproate therapy for prevention of posttraumatic seizures: A randomized trial.","volume":"91","author":"Temkin","year":"1999","journal-title":"J Neurosurg"},{"key":"R35-20241001","doi-asserted-by":"crossref","first-page":"e000377","DOI":"10.1136\/bmjno-2022-000377","article-title":"Efficacy of 48 hours dose of phenytoin in prevention of early post-traumatic seizure.","volume":"5","author":"Oyemolade","year":"2023","journal-title":"BMJ Neurol Open"},{"key":"R36-20241001","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3171\/jns.1999.91.4.0588","article-title":"Side effects and mortality associated with use of phenytoin for early posttraumatic seizure prophylaxis.","volume":"91","author":"Haltiner","year":"1999","journal-title":"J Neurosurg"},{"key":"R37-20241001","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00134-022-06702-4","article-title":"Management of moderate to severe traumatic brain injury: An update for the intensivist.","volume":"48","author":"Meyfroidt","year":"2022","journal-title":"Intensive Care Med"},{"key":"R38-20241001","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1212\/01.WNL.0000031432.05543.14","article-title":"Practice parameter: Antiepileptic drug prophylaxis in severe traumatic brain injury: Report of the Quality Standards Subcommittee of the American Academy of Neurology.","volume":"60","author":"Chang","year":"2003","journal-title":"Neurology"},{"key":"R39-20241001","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00268-017-4373-0","article-title":"Early seizure prophylaxis in traumatic brain injuries revisited: A prospective observational study.","volume":"42","author":"Khor","year":"2018","journal-title":"World J Surg"},{"key":"R40-20241001","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.wneu.2018.11.076","article-title":"The effectiveness of antiepileptic medications as prophylaxis of early seizure in patients with traumatic brain injury compared with placebo or no treatment: A systematic review and meta-analysis.","volume":"122","author":"Wat","year":"2019","journal-title":"World Neurosurg"},{"key":"R41-20241001","first-page":"CD009900","article-title":"Pharmacological treatments for preventing epilepsy following traumatic head injury.","volume":"2015","author":"Thompson","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R42-20241001","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: Concepts and models for multi-arm studies.","volume":"3","author":"Higgins","year":"2012","journal-title":"Res Synth Methods"},{"key":"R43-20241001","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1164\/rccm.202305-0790CP","article-title":"Accounting for competing events when evaluating long-term outcomes in survivors of critical illness.","volume":"208","author":"Angriman","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"R44-20241001","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1513\/AnnalsATS.202110-1188PS","article-title":"Beyond confounding: Identifying selection bias in observational pulmonary and critical care research.","volume":"19","author":"Admon","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"R45-20241001","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/01.ede.0000135174.63482.43","article-title":"A structural approach to selection bias.","volume":"15","author":"Hern\u00e1n","year":"2004","journal-title":"Epidemiology"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001160","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T16:01:18Z","timestamp":1727798478000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001160","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,25]]}}}